GeneTex neuroscience antibodies
30 September, 2019GeneTex offers an extensive collection of high-quality antibodies for research of the central nervous system.
AdipoGen animal-free recombinant monoclonal antibodies (RecMAbs)
26 August, 2019AdipoGen develops recombinant monoclonal antibodies (RecMAbs) without the use of animals. The antibodies are created using an in vitro technology, antibody phage display — an alternative to the hybridoma technology that circumvents the limitations of the immune system.
Absolute Antibody mouse bispecific antibody reagents
15 May, 2019Absolute Antibody's murine bispecific reagents enable researchers and drug developers to more easily evaluate potential bispecific combinations in mouse models.
Jackson ImmunoResearch Anti-Alpaca secondary antibodies
29 April, 2019The Anti-Alpaca secondary antibody product line targets the IgG repertoire of camelid immunoglobulins, including whole molecule, subclass and VHH domain specificities. They are raised against alpaca and cross-react with llama.
Edible antibodies to treat gastrointestinal disorders
12 April, 2019Scientists have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
Leica Biosystems PD-L1 BOND antibody
05 December, 2018Leica Biosystems' PD-L1 BOND antibody is designed for use on their fully automated BOND IHC and ISH staining platform.
Are your results reproducible?
01 December, 2018The scientific community is currently facing a reproducibility crisis. Over 70% of researchers are failing to reproduce published experiments.
Recombinant human antibody panel combats snake venom
04 October, 2018Biotechnology company IONTAS has announced a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.
Bio-Rad anti-ranibizumab antibodies
02 August, 2018Bio-Rad Laboratories has launched a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A (VEGF-A).
Thermo Fisher Scientific to host antibody data on its website
10 July, 2018Thermo Fisher Scientific will utilise BenchSci's machine learning platform to mine antibody data published in peer-reviewed scientific journals.
The Native Antigen Company bacterial and viral antigens
31 May, 2018The Native Antigen Company is an expert in the production of bacterial and viral antigens, specialising in the development and manufacture of native and recombinant viral and bacterial antigens.
Bio-Rad Laboratories anti-pembrolizumab and anti-nivolumab antibodies
29 May, 2018Bio-Rad Laboratories has launched a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs pembrolizumab (Keytruda) and nivolumab (Opdivo). Anti-pembrolizumab and anti-nivolumab antibodies are designed for use in bioanalytical assays to monitor the drug levels in cancer patients.
Bio-Rad Laboratories anti-vedolizumab antibodies
17 May, 2018Bio-Rad's anti-vedolizumab antibodies include four recombinant monoclonal anti-idiotypic antibodies that are highly specific for the humanised IgG1 kappa antibody drug vedolizumab, and are suitable for development of bioanalytical and patient monitoring assays.
Bio-Rad StarBright Blue 520 Fluorescent Secondary Antibodies
16 May, 2018Bio-Rad Laboratories has announced the StarBright Blue 520 Fluorescent Secondary Antibodies — fluorescent dye-labelled secondary antibodies for use in multiplex western blotting.
AdipoGen Life Sciences anti-α-Tubulin, recombinant antibodies
19 March, 2018AdipoGen Life Sciences' anti-α-Tubulin monoclonal antibodies (recombinant) are composed of human variable regions (VH and VL) (λ-chain) of immunoglobulin fused to the human lgG2 Fc domain.
